Clin Res Cardiol (2022). https://doi.org/10.1007/s00392-022-02002-5 |
||
Comparison of MitraClip with surgical mitral valve repair in patients with functional mitral regurgitation using a meta-analytic approach | ||
D. Felbel1, M. Paukovitsch1, R. Förg1, T. Stephan1, B. Mayer2, W. Rottbauer1, S. Markovic1, L. Schneider1 | ||
1Klinik für Innere Medizin II, Universitätsklinikum Ulm, Ulm; 2Institut für Epidemiologie und Medizinische Biometrie, Ulm; | ||
Background The evidence regarding favorable treatment of patients with functional mitral regurgitation (FMR) using transcatheter edge-to-edge repair (TEER) is constantly growing. However, there is only few data directly comparing TEER and conventional surgical mitral valve repair (SMVR).
Objectives
Methods
Results 22 MC and 22 SMVR studies comprising 4356 and 2054 patients were included in our analysis. Patients in the MC cohort presented with higher age (71.9 ±1.7 vs. 64.1 ±5.72 years; p<0.001) and a greater burden of comorbidities like hypertension (74.5% ±9.8 vs. 55.1% ±8.1; p<0.001), atrial fibrillation (51.9% ±13.5 vs. 25.9 ±15.3; p<0.001), history of CABG (37.9% ±10.7 vs. 11.2% ±9.3; p<0.001) and chronic renal disease (34.4% ±14.5 vs. 20.3% ±10.2; p=0.028). Consequently, MC patients showed a higher logistic Euro Score (22.3 ±4.4 vs. 11.4 ±2.5; p<0.001). In-hospital mortality was significantly lower in the MC cohort (3% [95%-CI 0.02 – 0.04; I2=0%] vs. 7% [95%-CI 0.05– 0.08; I2=38%]). 30-day mortality was comparable between both groups (MC: 4% [95%-CI 0.03 - 0.05; I2=45%] vs. SMVR: 4% [0.03 - 0.07; I2=55%]) and 1-year mortality did not differ significantly (18% [95%-CI 0.15 - 0.21; I2=67%] vs. 11% [0.06 - 0.17; I2=72%]). Meta-regression analysis revealed NYHA class IV as a significant moderator of 30-day mortality for the MC procedure (estimate 3.14; 95%-CI 1.31 – 4.98; p<0.001).
Conclusion Despite considerably higher age, comorbidity burden and logistic Euro Score, in-hospital mortality was substantially lower in patients treated with TEER. 30-day and 1-year mortality did not differ significantly between the MC and SMVR cohorts. |
||
https://dgk.org/kongress_programme/jt2022/aP1565.html |